Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.8B | 3.1B | 3.3B | 3.1B |
| Cost of revenue | 1.3B | 1.4B | 1.4B | 1.3B |
| Gross profit | 1.6B | 1.7B | 1.9B | 1.8B |
| Operating expense | ||||
| Research & development | 547M | 612M | 577M | 594M |
| Selling general and admin | 281M | 323M | 265M | 270M |
| Other operating expenses | — | — | — | — |
| Operating income | 705M | 715M | 995M | 900M |
| Non operating interest income | ||||
| Income | 35M | 35M | 36M | 39M |
| Expense | 106M | 100M | 96M | 97M |
| Other income expense | 18M | -40M | -5M | -4M |
| Pretax income | 631M | 584M | 908M | 821M |
| Tax provision | 130M | 77M | 173M | 154M |
| Net income | 497M | 505M | 729M | 664M |
| Basic EPS | 1.9 | 2.0 | 2.8 | 2.6 |
| Diluted EPS | 1.9 | 1.9 | 2.8 | 2.5 |
| Basic average shares | 285.1M | 285.8M | 285.9M | 287.0M |
| Diluted average shares | 286.5M | 288.3M | 289.6M | 290.7M |
| EBITDA | 946M | 953M | 1.2B | 1.1B |
| Net income from continuing op. | 497M | 505M | 729M | 664M |
| Minority interests | -7M | -10M | -11M | -6M |
| Preferred stock dividends | — | — | — | — |